Preeclampsia: long-term consequences for vascular health

References

• RobertsJMGammillHSPreeclampsia: recent insightsHypertension20054661243124916230510
   PubMed Web of Science ®Google Scholar
• GilbertJSRyanMJLaMarcaBBSedeekMMurphySRGrangerJPPathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunctionAm J Physiol Heart Circ Physiol20082942H541H55018055511
   PubMed Web of Science ®Google Scholar
• GrangerJPAlexanderBTBennettWAKhalilRAPathophysiology of pregnancy-induced hypertensionAm J Hypertens2001146 Pt 2178S185S11411754
   PubMed Web of Science ®Google Scholar
• GrangerJPAlexanderBTLlinasMTBennettWAKhalilRAPathophysiology of preeclampsia: linking placental ischemia/hypoxia with microvascular dysfunctionMicrocirculation20029314716012080413
   PubMed Web of Science ®Google Scholar
• NorisMPericoNRemuzziGMechanisms of disease: Pre-eclampsiaNat Clin Pract Nephrol2005129811416932375
   PubMedGoogle Scholar
• RedmanCWSargentILLatest advances in understanding preeclampsiaScience200530857281592159415947178
   PubMed Web of Science ®Google Scholar
• SankaralingamSArenasIALaluMMDavidgeSTPreeclampsia: current understanding of the molecular basis of vascular dysfunctionExpert Rev Mol Med20068312016438753
   PubMedGoogle Scholar
• SibaiBDekkerGKupfermincMPre-eclampsiaLancet2005365946178579915733721
   PubMed Web of Science ®Google Scholar
• BrennanLJMortonJSDavidgeSTVascular dysfunction in preeclampsiaMicrocirculation201421141423890192
   PubMed Web of Science ®Google Scholar
• GoulopoulouSDavidgeSTMolecular mechanisms of maternal vascular dysfunction in preeclampsiaTrends Mol Med2015212889725541377
   PubMed Web of Science ®Google Scholar
• SandrimVCPaleiACMetzgerIFGomesVACavalliRCTanus-SantosJENitric oxide formation is inversely related to serum levels of antiangiogenic factors soluble fms-like tyrosine kinase-1 and soluble endogline in preeclampsiaHypertension200852240240718574068
   PubMed Web of Science ®Google Scholar
• MurphySRLaMarcaBBParrishMCockrellKGrangerJPControl of soluble fms-like tyrosine-1 (sFlt-1) production response to placental ischemia/hypoxia: role of tumor necrosis factor-alphaAm J Physiol Regul Integr Comp Physiol20133042R130R13523193111
   PubMed Web of Science ®Google Scholar
• WangARanaSKarumanchiSAPreeclampsia: the role of angiogenic factors in its pathogenesisPhysiology (Bethesda)20092414715819509125
   PubMed Web of Science ®Google Scholar
• SerranoNCCasasJPDiazLAEndothelial NO synthase genotype and risk of preeclampsia: a multicenter case-control studyHypertension200444570270715364897
   PubMed Web of Science ®Google Scholar
• KinneyMVLawnJEHowsonCPBelizanJ15 Million preterm births annually: what has changed this year?Reprod Health201292823148557
   PubMed Web of Science ®Google Scholar
• ChapmanABAbrahamWTZamudioSTemporal relationships between hormonal and hemodynamic changes in early human pregnancyKidney Int1998546205620639853271
   PubMed Web of Science ®Google Scholar
• GarovicVDHaymanSRHypertension in pregnancy: an emerging risk factor for cardiovascular diseaseNat Clin Pract Nephrol200731161362217957198
   PubMedGoogle Scholar
• AhmedRDunfordJMehranRRobsonSKunadianVPre-eclampsia and future cardiovascular risk among women: a reviewJ Am Coll Cardiol201463181815182224613324
   PubMed Web of Science ®Google Scholar
• Muller-DeileJSchifferMPreeclampsia from a renal point of view: Insides into disease models, biomarkers and therapyWorld J Nephrol20143416918125374810
   PubMedGoogle Scholar
• GibsonHMPlasma volume and glomerular filtration rate in pregnancy and their relation to differences in fetal growthJ Obstet Gynaecol Br Commonw19738012106710744761381
   PubMedGoogle Scholar
• VikseBEIrgensLMLeivestadTSkjaervenRIversenBMPreeclampsia and the risk of end-stage renal diseaseN Engl J Med2008359880080918716297
   PubMed Web of Science ®Google Scholar
• GarovicVDWagnerSJTurnerSTUrinary podocyte excretion as a marker for preeclampsiaAm J Obstet Gynecol20071964320.e1e717403404
   PubMed Web of Science ®Google Scholar
• CraiciIMWagnerSJBaileyKRPodocyturia predates proteinuria and clinical features of preeclampsia: longitudinal prospective studyHypertension20136161289129623529165
   PubMed Web of Science ®Google Scholar
• AitaKEtohMHamadaHAcute and transient podocyte loss and proteinuria in preeclampsiaNephron Clin Pract20091122c65c7019390204
   PubMedGoogle Scholar
• MatsubaraKMatsubaraYHyodoSKatayamaTItoMRole of nitric oxide and reactive oxygen species in the pathogenesis of preeclampsiaJ Obstet Gynaecol Res201036223924720492372
   PubMed Web of Science ®Google Scholar
• RobertsJMVon Versen-HoeynckFMaternal fetal/placental interactions and abnormal pregnancy outcomesHypertension2007491151617116760
   PubMed Web of Science ®Google Scholar
• ShaamashAHElsnosyEDMakhloufAMZakhariMMIbrahimOAHM EL-dMaternal and fetal serum nitric oxide (NO) concentrations in normal pregnancy, pre-eclampsia and eclampsiaInt J Gynaecol Obstet200068320721410699190
   PubMed Web of Science ®Google Scholar
• MurphySRLaMarcaBCockrellKAranyMGrangerJPL-arginine supplementation abolishes the blood pressure and endothelin response to chronic increases in plasma sFlt-1 in pregnant ratsAm J Physiol Regul Integr Comp Physiol20123022R259R26322071155
   PubMed Web of Science ®Google Scholar
• SandrimVCMontenegroMFPaleiACIncreased circulating cell-free hemoglobin levels reduce nitric oxide bioavailability in preeclampsiaFree Radic Biol Med201049349350020510352
   PubMed Web of Science ®Google Scholar
• PimentelAMPereiraNRCostaCAL-arginine-nitric oxide pathway and oxidative stress in plasma and platelets of patients with pre-eclampsiaHypertens Res201336978378823575380
   PubMed Web of Science ®Google Scholar
• MolnarMSutoTTothTHertelendyFProlonged blockade of nitric oxide synthesis in gravid rats produces sustained hypertension, pro-teinuria, thrombocytopenia, and intrauterine growth retardationAm J Obstet Gynecol19941705 Pt 1145814667909994
   PubMed Web of Science ®Google Scholar
• VosatkaRJHassounPMHarvey-WilkesKBDietary L-arginine prevents fetal growth restriction in ratsAm J Obstet Gynecol199817822422469500481
   PubMed Web of Science ®Google Scholar
• NeriIMazzaVGalassiMCVolpeAFacchinettiFEffects of L-arginine on utero-placental circulation in growth-retarded fetusesActa Obstet Gynecol Scand19967532082128607330
   PubMed Web of Science ®Google Scholar
• MoncadaSHiggsAThe L-arginine-nitric oxide pathwayN Engl J Med199332927200220127504210
   PubMed Web of Science ®Google Scholar
• MoncadaSHiggsEAThe discovery of nitric oxide and its role in vascular biologyBr J Pharmacol2006147Suppl 1S193S20116402104
   PubMed Web of Science ®Google Scholar
• NelsonSHSteinslandOSWangYYallampalliCDongYLSanchezJMIncreased nitric oxide synthase activity and expression in the human uterine artery during pregnancyCirc Res200087540641110969039
   PubMed Web of Science ®Google Scholar
• SandrimVCPaleiACCavalliRCeNOS haplotypes associated with gestational hypertension or preeclampsiaPharmacogenomics J200891014671473
   Google Scholar
• SandrimVCPaleiACLuizonMRIzidoro-ToledoTCCavalliRCTanus-SantosJEeNOS haplotypes affect the responsiveness to antihypertensive therapy in preeclampsia but not in gestational hypertensionPharmacogenomics J2010101404519704415
   PubMed Web of Science ®Google Scholar
• NorisMTodeschiniMCassisPL-arginine depletion in preeclampsia orients nitric oxide synthase toward oxidant speciesHypertension200443361462214744923
   PubMed Web of Science ®Google Scholar
• EleuterioNMPaleiACRangel MachadoJSTanus-SantosJECavalliRCSandrimVCRelationship between adiponectin and nitrite in healthy and preeclampsia pregnanciesClin Chim Acta201342311211523643962
   PubMed Web of Science ®Google Scholar
• SandrimVCPaleiACMetzgerIFCavalliRCDuarteGTanus-SantosJEInterethnic differences in ADMA concentrations and negative association with nitric oxide formation in preeclampsiaClin Chim Acta201041119–201457146020570587
   PubMed Web of Science ®Google Scholar
• MaynardSEMinJYMerchanJExcess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsiaJ Clin Invest2003111564965812618519
   PubMed Web of Science ®Google Scholar
• SankaralingamSXuHDavidgeSTArginase contributes to endothelial cell oxidative stress in response to plasma from women with preeclampsiaCardiovasc Res201085119420319684035
   PubMed Web of Science ®Google Scholar
• AlpoimPNGodoiLCFreitasLGGomesKBDusseLMAssessment of L-arginine asymmetric 1 dimethyl (ADMA) in early-onset and late-onset (severe) preeclampsiaNitric Oxide201333818223876347
   PubMed Web of Science ®Google Scholar
• Mutlu-TurkogluUAykac-TokerGIbrahimogluLAdemogluEUysalMPlasma nitric oxide metabolites and lipid peroxide levels in preeclamptic pregnant women before and after deliveryGynecol Obstet Invest199948424725010592426
   PubMed Web of Science ®Google Scholar
• AlexanderBTKassabSEMillerMTReduced uterine perfusion pressure during pregnancy in the rat is associated with increases in arterial pressure and changes in renal nitric oxideHypertension20013741191119511304523
   PubMed Web of Science ®Google Scholar
• CrewsJKHerringtonJNGrangerJPKhalilRADecreased endothelium-dependent vascular relaxation during reduction of uterine perfusion pressure in pregnant ratHypertension2000351 Pt 236737210642326
   PubMed Web of Science ®Google Scholar
• WalshSKEnglishFAJohnsEJKennyLCPlasma-mediated vascular dysfunction in the reduced uterine perfusion pressure model of preeclampsia: a microvascular characterizationHypertension200954234535119564546
   PubMed Web of Science ®Google Scholar
• AmaralLMCorneliusDCHarmonAMoseleyJMartinJNJrLaMarcaB17-hydroxyprogesterone caproate significantly improves clinical characteristics of preeclampsia in the reduced uterine perfusion pressure rat modelHypertension201565122523125368030
   PubMed Web of Science ®Google Scholar
• LamarcaBEndothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsiaMinerva Ginecol201264430932022728575
   PubMedGoogle Scholar
• CartyDMAndersonLADuncanCNPeripheral arterial tone: assessment of microcirculatory function in pregnancyJ Hypertens201230111712322052066
   PubMed Web of Science ®Google Scholar
• SpasojevicMSmithSAMorrisJMGalleryEDPeripheral arterial pulse wave analysis in women with pre-eclampsia and gestational hypertensionBJOG2005112111475147816225565
   PubMed Web of Science ®Google Scholar
• ClarkDESmithSKHeYA vascular endothelial growth factor antagonist is produced by the human placenta and released into the maternal circulationBiol Reprod1998596154015489828203
   PubMed Web of Science ®Google Scholar
• MurphySRLaMarcaBBCockrellKGrangerJPRole of endothelin in mediating soluble fms-like tyrosine kinase 1-induced hypertension in pregnant ratsHypertension201055239439820026766
   PubMed Web of Science ®Google Scholar
• PruthiDKhankinEVBlantonRMExposure to experimental preeclampsia in mice enhances the vascular response to future injuryHypertension201565486387025712723
   PubMed Web of Science ®Google Scholar
• NooriMDonaldAEAngelakopoulouAHingoraniADWilliamsDJProspective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertensionCirculation2010122547848720644016
   PubMed Web of Science ®Google Scholar
• WolfMHubelCALamCPreeclampsia and future cardiovascular disease: potential role of altered angiogenesis and insulin resistanceJ Clin Endocrinol Metab200489126239624315579783
   PubMed Web of Science ®Google Scholar
• VaccaPMorettaLMorettaAMingariMCOrigin, phenotype and function of human natural killer cells in pregnancyTrends Immunol2011321151752321889405
   PubMed Web of Science ®Google Scholar
• CidMCKleinmanHKGrantDSSchnaperHWFauciASHoffmanGSEstradiol enhances leukocyte binding to tumor necrosis factor (TNF)-stimulated endothelial cells via an increase in TNF-induced adhesion molecules E-selectin, intercellular adhesion molecule type 1, and vascular cell adhesion molecule type 1J Clin Invest199493117257506711
   PubMed Web of Science ®Google Scholar
• GrangerJPAlexanderBTLlinasMTBennettWAKhalilRAPathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunctionHypertension2001383 Pt 271872211566964
   PubMed Web of Science ®Google Scholar
• KeiserSDVeillonEWParrishMREffects of 17-hydroxypro-gesterone on tumor necrosis factor-alpha-induced hypertension during pregnancyAm J Hypertens200922101120112519745821
   PubMed Web of Science ®Google Scholar
• LaMarcaBBCockrellKSullivanEBennettWGrangerJPRole of endothelin in mediating tumor necrosis factor-induced hypertension in pregnant ratsHypertension2005461828615928030
   PubMed Web of Science ®Google Scholar
• LaMarcaBParrishMRayLFHypertension in response to autoantibodies to the angiotensin II type I receptor (AT1-AA) in pregnant rats: role of endothelin-1Hypertension200954490590919704104
   PubMed Web of Science ®Google Scholar
• NovotnySRWallaceKHeathJActivating autoantibodies to the angiotensin II type I receptor play an important role in mediating hypertension in response to adoptive transfer of CD4+ T lymphocytes from placental ischemic ratsAm J Physiol Regul Integr Comp Physiol201230210R1197R120122461177
   PubMed Web of Science ®Google Scholar
• TaylorRNde GrootCJChoYKLimKHCirculating factors as markers and mediators of endothelial cell dysfunction in preeclampsiaSemin Reprod Endocrinol199816117319654604
   PubMedGoogle Scholar
• WallaceKRichardsSDhillonPCD4+ T-helper cells stimulated in response to placental ischemia mediate hypertension during pregnancyHypertension201157594995521464392
   PubMed Web of Science ®Google Scholar
• WallaceKNovotnySHeathJHypertension in response to CD4(+) T cells from reduced uterine perfusion pregnant rats is associated with activation of the endothelin-1 systemAm J Physiol Regul Integr Comp Physiol20123032R144R14922647295
   PubMed Web of Science ®Google Scholar
• WuCFHuangFDSuiRFSunJXPreeclampsia serum upregulates CD40/CD40L expression and induces apoptosis in human umbilical cord endothelial cellsReprod Biol Endocrinol2012102822510585
   PubMed Web of Science ®Google Scholar
• ZhouCCIraniRADaiYAutoantibody-mediated IL-6-dependent endothelin-1 elevation underlies pathogenesis in a mouse model of preeclampsiaJ Immunol2011186106024603421482739
   PubMed Web of Science ®Google Scholar
• BenyoDFMilesTMConradKPHypoxia stimulates cytokine production by villous explants from the human placentaJ Clin Endocrinol Metab1997825158215889141553
   PubMed Web of Science ®Google Scholar
• ConradKPBenyoDFPlacental cytokines and the pathogenesis of preeclampsiaAm J Reprod Immunol19973732402499127646
   PubMed Web of Science ®Google Scholar
• RobertsJMPearsonGCutlerJLindheimerMPregnancy NWGoRoHDSummary of the NHLBI Working Group on Research on Hypertension During PregnancyHypertension200341343744512623940
   PubMed Web of Science ®Google Scholar
• RobertsJMLainKYRecent Insights into the pathogenesis of pre-eclampsiaPlacenta200223535937212061851
   PubMed Web of Science ®Google Scholar
• LamarcaBThe role of immune activation in contributing to vascular dysfunction and the pathophysiology of hypertension during preeclampsiaMinerva Ginecol201062210512020502423
   PubMedGoogle Scholar
• LaMarcaBBBennettWAAlexanderBTCockrellKGrangerJPHypertension produced by reductions in uterine perfusion in the pregnant rat: role of tumor necrosis factor-alphaHypertension20054641022102516144982
   PubMed Web of Science ®Google Scholar
• ZenclussenACFestSJoachimRKlappBFArckPCIntroducing a mouse model for pre-eclampsia: adoptive transfer of activated Th1 cells leads to pre-eclampsia-like symptoms exclusively in pregnant miceEur J Immunol200434237738714768042
   PubMed Web of Science ®Google Scholar
• SaitoSUmekageHSakamotoYIncreased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsiaAm J Reprod Immunol199941529730610378024
   PubMed Web of Science ®Google Scholar
• SaitoSSakaiMSasakiYTanebeKTsudaHMichimataTQuantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsiaClin Exp Immunol1999117355055510469061
   PubMed Web of Science ®Google Scholar
• ToldiGRigoJJrStenczerBVasarhelyiBMolvarecAIncreased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsiaAm J Reprod Immunol201166322322921306467
   PubMed Web of Science ®Google Scholar
• SaitoSNakashimaAShimaTItoMTh1/Th2/Th17 and regulatory T-cell paradigm in pregnancyAm J Reprod Immunol201063660161020455873
   PubMed Web of Science ®Google Scholar
• SaitoSTh17 cells and regulatory T cells: new light on pathophysiology of preeclampsiaImmunol Cell Biol201088661561720498674
   PubMed Web of Science ®Google Scholar
• JianjunZYaliHZhiqunWMingmingZXiaZImbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsiaAm J Reprod Immunol2010631384519912158
   PubMed Web of Science ®Google Scholar
• Darmochwal-KolarzDKludka-SternikMTabarkiewiczJThe predominance of Th17 lymphocytes and decreased number and function of Treg cells in preeclampsiaJ Reprod Immunol2012932758122370101
   PubMed Web of Science ®Google Scholar
• El-KabarityRHNaguibAHSerum levels of IL-18, IL-12 and TH-1/TH-2 ratio in patients with pre-eclampsiaEgypt J Immunol20111811823082474
   PubMedGoogle Scholar
• DongMHeJWangZXieXWangHPlacental imbalance of Th1-and Th2-type cytokines in preeclampsiaActa Obstet Gynecol Scand200584878879316026406
   PubMed Web of Science ®Google Scholar
• SaitoSSakaiMTh1/Th2 balance in preeclampsiaJ Reprod Immunol200359216117312896820
   PubMed Web of Science ®Google Scholar
• BorzychowskiAMCroyBAChanWLRedmanCWSargentILChanges in systemic type 1 and type 2 immunity in normal pregnancy and pre-eclampsia may be mediated by natural killer cellsEur J Immunol200535103054306316134082
   PubMed Web of Science ®Google Scholar
• WallaceKCorneliusDCScottJCD4+ T cells are important mediators of oxidative stress that cause hypertension in response to placental ischemiaHypertension20146451151115825259742
   PubMed Web of Science ®Google Scholar
• Laresgoiti-ServitjeEA leading role for the immune system in the pathophysiology of preeclampsiaJ Leukoc Biol201394224725723633414
   PubMed Web of Science ®Google Scholar
• DhillionPWallaceKHerseFIL-17-mediated oxidative stress is an important stimulator of AT1-AA and hypertension during pregnancyAm J Physiol Regul Integr Comp Physiol20123034R353R35822718806
   PubMed Web of Science ®Google Scholar
• CorneliusDCWallaceKKippronoLDhillionPMoseleyJLamarcaBEndothelin-1 is not a Mechanism of IL-17 Induced Hypertension during PregnancyMed J Obstet Gynecol201311pii:1006
   Google Scholar
• CorneliusDCHoggJPScottJAdministration of interleukin-17 soluble receptor C suppresses TH17 cells, oxidative stress, and hypertension in response to placental ischemia during pregnancyHypertension20136261068107324060899
   PubMed Web of Science ®Google Scholar
• MaddurMSMiossecPKaveriSVBayryJTh17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategiesAm J Pathol2012181181822640807
   PubMed Web of Science ®Google Scholar
• VitoratosNEconomouEIavazzoCPanoulisKCreatsasGMaternal serum levels of TNF-alpha and IL-6 long after delivery in preeclamptic and normotensive pregnant womenMediators Inflamm2010201090864921253506
   PubMed Web of Science ®Google Scholar
• KvehaugenASDechendRRamstadHBTroisiRFugelsethDStaffACEndothelial function and circulating biomarkers are disturbed in women and children after preeclampsiaHypertension2011581636921606387
   PubMed Web of Science ®Google Scholar
• ToldiGSaitoSShimaTThe frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsiaAm J Reprod Immunol201268217518022510013
   PubMed Web of Science ®Google Scholar
• TilburgsTRoelenDLvan der MastBJDifferential distribution of CD4(+)CD25(bright) and CD8(+)CD28(−) T-cells in decidua and maternal blood during human pregnancyPlacenta200627Suppl AS47S5316442616
   PubMedGoogle Scholar
• Santner-NananBPeekMJKhanamRSystemic increase in the ratio between Foxp3+ and IL-17-producing CD4+ T cells in healthy pregnancy but not in preeclampsiaJ Immunol2009183117023703019915051
   PubMed Web of Science ®Google Scholar
• PrinsJRBoelensHMHeimwegJPreeclampsia is associated with lower percentages of regulatory T cells in maternal bloodHypertens Pregnancy200928330031119412837
   PubMed Web of Science ®Google Scholar
• GeigerTLTauroSNature and nurture in Foxp3(+) regulatory T cell development, stability, and functionHum Iimmunol2012733232239
   PubMed Web of Science ®Google Scholar
• PetersonRARegulatory T-cells: diverse phenotypes integral to immune homeostasis and suppressionToxicol Pathol201240218620422222887
   PubMed Web of Science ®Google Scholar
• ShimaTSasakiYItohMRegulatory T cells are necessary for implantation and maintenance of early pregnancy but not late pregnancy in allogeneic miceJ Reprod Immunol201085212112920439117
   PubMed Web of Science ®Google Scholar
• BettiniMVignaliDARegulatory T cells and inhibitory cytokines in autoimmunityCurr Opin Immunol200921661261819854631
   PubMed Web of Science ®Google Scholar
• ArckPCHecherKFetomaternal immune cross-talk and its consequences for maternal and offspring’s healthNat Med201319554855623652115
   PubMed Web of Science ®Google Scholar
• AluvihareVRKallikourdisMBetzAGRegulatory T cells mediate maternal tolerance to the fetusNat Immunol20045326627114758358
   PubMed Web of Science ®Google Scholar
• JorgensenKTPedersenBVJacobsenSBiggarRJFrischMNational cohort study of reproductive risk factors for rheumatoid arthritis in Denmark: a role for hyperemesis, gestational hypertension and pre-eclampsia?Ann Rheum Dis201069235836319289384
   PubMed Web of Science ®Google Scholar
• JorgensenKTHarpsoeMCJacobsenSJessTFrischMIncreased risk of rheumatoid arthritis in women with pregnancy complications and poor self-rated health: a study within the Danish National Birth CohortRheumatology (Oxford)20145381513151924692576
   PubMed Web of Science ®Google Scholar
• PerittDRobertsonSGriGShoweLAste-AmezagaMTrinchieriGCutting Edge: Differentiation of Human NK Cells into NK1 and NK2 SubsetsThe Journal of Immunology199816111582158249834059
   PubMed Web of Science ®Google Scholar
• KerdilesYUgoliniSVivierET cell regulation of natural killer cellsJ Exp Med201321061065106823733834
   PubMed Web of Science ®Google Scholar
• KatsumotoTKimuraMYamashitaMSTAT6-dependent differentiation and production of IL-5 and IL-13 in murine NK2 cellsJ Immunol200417384967497515470039
   PubMed Web of Science ®Google Scholar
• Al OmarSFlanaganBFAlmehmadiMChristmasSEThe effects of IL-17 upon human natural killer cellsCytokine201362112313023490420
   PubMed Web of Science ®Google Scholar
• FukuiAYokotaMFunamizuAChanges of NK cells in preeclampsiaAm J Reprod Immunol201267427828622364232
   PubMed Web of Science ®Google Scholar
• HedrickCCLymphocytes in atherosclerosisArterioscler Thromb Vasc Biol201535225325725609772
   PubMed Web of Science ®Google Scholar
• SelathuraiADeswaerteVKanellakisPNatural killer (NK) cells augment atherosclerosis by cytotoxic-dependent mechanismsCardiovasc Res2014102112813724469537
   PubMed Web of Science ®Google Scholar
• KossmannSSchwenkMHausdingMAngiotensin II-induced vascular dysfunction depends on interferon-gamma-driven immune cell recruitment and mutual activation of monocytes and NK-cellsArterioscler Thromb Vasc Biol20133361313131923520167
   PubMed Web of Science ®Google Scholar
• Martinez-RodriguezJEMunne-ColladoJRasalRExpansion of the NKG2C+ natural killer-cell subset is associated with high-risk carotid atherosclerotic plaques in seropositive patients for human cytomegalovirusArterioscler Thromb Vasc Biol201333112653265923968979
   PubMed Web of Science ®Google Scholar
• GuptaAKHaslerPHolzgreveWHahnSNeutrophil NETs: a novel contributor to preeclampsia-associated placental hypoxia?Semin Immunopathol200729216316717621701
   PubMed Web of Science ®Google Scholar
• WallukatGHomuthVFischerTPatients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptorJ Clin Invest1999103794595210194466
   PubMed Web of Science ®Google Scholar
• HerseFLaMarcaBAngiotensin II type 1 receptor autoantibody (AT1-AA)-mediated pregnancy hypertensionAm J Reprod Immunol201369441341823279165
   PubMed Web of Science ®Google Scholar
• YangSZhongQQiuZAngiotensin II receptor type 1 autoantibodies promote endothelial microparticles formation through activating p38 MAPK pathwayJ Hypertens201432476277024609215
   PubMed Web of Science ®Google Scholar
• ThwayTMShlykovSGDayMCAntibodies from preeclamptic patients stimulate increased intracellular Ca2+ mobilization through angiotensin receptor activationCirculation2004110121612161915381659
   PubMed Web of Science ®Google Scholar
• DechendRHomuthVWallukatGAT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factorCirculation2000101202382238710821814
   PubMed Web of Science ®Google Scholar
• DragunDMullerDNBrasenJHAngiotensin II type 1-receptor activating antibodies in renal-allograft rejectionN Engl J Med2005352655856915703421
   PubMed Web of Science ®Google Scholar
• FuMLHerlitzHSchulzeWAutoantibodies against the angiotensin receptor (AT1) in patients with hypertensionJ Hypertens200018794595310930193
   PubMed Web of Science ®Google Scholar
• LiaoYHWeiYMWangMWangZHYuanHTChengLXAutoantibodies against AT1-receptor and alpha1-adrenergic receptor in patients with hypertensionHypertens Res200225464164612358154
   PubMed Web of Science ®Google Scholar
• FischerTWallukatGSchneiderMPSchlembachDMunzWHomuthVHELLP syndrome in the 18th week of gestation in association with elevated angiotensin AT(1)-receptor autoantibodiesEur J Obstet Gynecol Reprod Biol200197225525711451561
   PubMed Web of Science ®Google Scholar
• ZhangLCuiLMiaoGBZhaoWSWangSYLiuXLStudy of autoantibodies against the G-protein-coupled beta 2- and alpha 1-adren-ergic and AT1 receptors in patients with primary hypertensionZhongguo Yi Xue Ke Xue Yuan Xue Bao2002244367369 Chinese12905654
   PubMedGoogle Scholar
• DechendRViedtCMullerDNAT1 receptor agonistic antibodies from preeclamptic patients stimulate NADPH oxidaseCirculation2003107121632163912668498
   PubMed Web of Science ®Google Scholar
• XiaYWenHBobstSDayMCKellemsREMaternal autoantibodies from preeclamptic patients activate angiotensin receptors on human trophoblast cellsJ Soc Gynecol Investig20031028293
   PubMedGoogle Scholar
• BobstSMDayMCGilstrapLC3rdXiaYKellemsREMaternal autoantibodies from preeclamptic patients activate angiotensin receptors on human mesangial cells and induce interleukin-6 and plasminogen activator inhibitor-1 secretionAm J Hypertens200518333033615797649
   PubMed Web of Science ®Google Scholar
• ChaiWZhangWJinZFengYKuangYZhiJAngiotensin II type I receptor agonistic autoantibody-induced apoptosis in neonatal rat cardiomyocytes is dependent on the generation of tumor necrosis factor-alphaActa Biochim Biophys Sin (Shanghai)2012441298499023089979
   PubMed Web of Science ®Google Scholar
• JinZWangJZhangWZhangGJiaoXZhiJChanges in cardiac structure and function in rats immunized by angiotensin type 1 receptor peptidesActa Biochim Biophys Sin (Shanghai)2011431297097622037945
   PubMed Web of Science ®Google Scholar
• WenzelKRajakumarAHaaseHAngiotensin II type 1 receptor antibodies and increased angiotensin II sensitivity in pregnant ratsHypertension2011581778421576625
   PubMed Web of Science ®Google Scholar
• BrewerJLiuRLuYEndothelin-1, oxidative stress, and endogenous angiotensin II: mechanisms of angiotensin II type I receptor autoantibody-enhanced renal and blood pressure response during pregnancyHypertension201362588689224041954
   PubMed Web of Science ®Google Scholar
• LaMarcaBWallukatGLlinasMHerseFDechendRGrangerJPAutoantibodies to the angiotensin type I receptor in response to placental ischemia and tumor necrosis factor alpha in pregnant ratsHypertension20085261168117218852381
   PubMed Web of Science ®Google Scholar
• LiJLaMarcaBReckelhoffJFA model of preeclampsia in rats: the reduced uterine perfusion pressure (RUPP) modelAm J Physiol Heart Circ Physiol20123031H1H822523250
   PubMed Web of Science ®Google Scholar
• DechendRGratzePWallukatGAgonistic autoantibodies to the AT1 receptor in a transgenic rat model of preeclampsiaHypertension200545474274615699466
   PubMed Web of Science ®Google Scholar
• LamarcaBBrewerJWallaceKIL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?Int J Interferon Cytokine Mediator Res2011201135964
   PubMedGoogle Scholar
• ParrishMRMurphySRRutlandSThe effect of immune factors, tumor necrosis factor-alpha, and agonistic autoantibodies to the angiotensin II type I receptor on soluble fms-like tyrosine-1 and soluble endoglin production in response to hypertension during pregnancyAm J Hypertens201023891191620431529
   PubMed Web of Science ®Google Scholar
• ParrishMRWallaceKTam TamKBHypertension in response to AT1-AA: role of reactive oxygen species in pregnancy-induced hypertensionAm J Hypertens201124783584021472019
   PubMed Web of Science ®Google Scholar
• XiaYKellemsREAngiotensin receptor agonistic autoantibodies and hypertension: preeclampsia and beyondCirc Res20131131788723788505
   PubMed Web of Science ®Google Scholar
• QuittererULotherHAbdallaSAT1 receptor heterodimers and angiotensin II responsiveness in preeclampsiaSemin Nephrol200424211511915017523
   PubMed Web of Science ®Google Scholar
• AbdAllaSLotherHel MassieryAQuittererUIncreased AT(1) receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsivenessNat Med2001791003100911533702
   PubMed Web of Science ®Google Scholar
• HubelCAWallukatGWolfMAgonistic angiotensin II type 1 receptor autoantibodies in postpartum women with a history of preeclampsiaHypertension200749361261717210828
   PubMed Web of Science ®Google Scholar
• WangHPZhangWHWangXFExposure to AT1 receptor autoantibodies during pregnancy increases susceptibility of the maternal heart to postpartum ischemia-reperfusion injury in ratsInt J Mol Sci2014157114951150924979132
   PubMed Web of Science ®Google Scholar
• BarkerDJFetal origins of coronary heart diseaseBr Heart J19936931951968461215
   PubMedGoogle Scholar
• YeungEHRobledoCBoghossianNZhangCMendolaPDevelopmental Origins of Cardiovascular DiseaseCurr Epidemiol Rep20141191625364653
   PubMedGoogle Scholar
• DavisEFLazdamMLewandowskiAJCardiovascular risk factors in children and young adults born to preeclamptic pregnancies: a systematic reviewPediatrics20121296e1552e156122614768
   PubMed Web of Science ®Google Scholar
• PoweCELevineRJKarumanchiSAPreeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular diseaseCirculation2011123242856286921690502
   PubMed Web of Science ®Google Scholar
• FraserANelsonSMMacdonald-WallisCAssociations of pregnancy complications with calculated cardiovascular disease risk and cardiovascular risk factors in middle age: the Avon Longitudinal Study of Parents and ChildrenCirculation2012125111367138022344039
   PubMed Web of Science ®Google Scholar
• MoscaLBenjaminEJBerraKEffectiveness-based guidelines for the prevention of cardiovascular disease in women – 2011 update: a guideline from the American Heart AssociationJ Am Coll Cardiol201157121404142321388771
   PubMed Web of Science ®Google Scholar
• KessousRShoham-VardiIParienteGSergienkoRSheinerELong-term maternal atherosclerotic morbidity in women with pre-eclampsiaHeart2015101644244625564558
   PubMed Web of Science ®Google Scholar
• LeeEJAhnKHHongSCLeeEHParkYKimBSRituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) chemotherapy for diffuse large B-cell lymphoma in pregnancy may be associated with preterm birthObstet Gynecol Sci201457652652925469343
   PubMedGoogle Scholar
• MandalPKDolaiTKBagchiBGhoshMKBoseSBhattacharyyaMB cell suppression in newborn following treatment of pregnant diffuse large B-cell lymphoma patient with rituximab containing regimenIndian J Pediatr201481101092109424562617
   PubMed Web of Science ®Google Scholar
• SangleSRLutaloPMDaviesRJKhamashtaMAD’CruzDPB-cell depletion therapy and pregnancy outcome in severe, refractory systemic autoimmune diseasesJ Autoimmun6201343555923608146
   PubMed Web of Science ®Google Scholar
• Ojeda-UribeMAfifNDahanEExposure to abatacept or rituximab in the first trimester of pregnancy in three women with autoimmune diseasesClin Rheumatol201332569570023292481
   PubMed Web of Science ®Google Scholar
• RingelsteinMHarmelJDistelmaierFNeuromyelitis optica and pregnancy during therapeutic B cell depletion: infant exposure to anti-AQP4 antibody and prevention of rebound relapses with low-dose rituximab postpartumMult Scler201319111544154723886825
   PubMed Web of Science ®Google Scholar
• SarnoMAMancariRAzimHAJrColomboNPeccatoriFAAre monoclonal antibodies a safe treatment for cancer during pregnancy?Immunotherapy20135773374123829624
   PubMed Web of Science ®Google Scholar
• BurnetteBLJentoftMAPorrataLFBoyceTGWitzigTESingle-agent rituximab for primary CNS lymphoma during pregnancy as a bridge to definitive managementJ Clin Oncol2014327e14e1724395859
   PubMed Web of Science ®Google Scholar